We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New High-Vacuum Pump Provides Increased Reliability and Efficiency

By LabMedica International staff writers
Posted on 19 Feb 2013
A new, high-performance turbomolecular pump is the first high-vacuum pump featuring a novel floating-suspension system that enables dramatic improvements over current technology.

Agilent Technologies (Santa Clara, CA, USA) introduces the TwisTorr 304 FS vacuum pump for use in a variety of applications and markets, including academic and government research, and the analytical, industrial, and nanotech/semiconductor industries. More...
Running at 60,000 rpm, it pumps up to 250 L/s for N2. It also provides dramatic improvements in reliability and increases light gas compression ratios 100-fold. TwisTorr drag stages guarantee high pumping speed and compression ratios for hydrogen and helium. The pump also provides unparalleled throughput and high foreline tolerance, as well as low power-consumption and operating temperature.

Coupled with the same superior performance as in Agilent’s existing line of patented TwisTorr solutions, the new system's breakthrough floating-suspension technology ensures low vibration and acoustical noise, optimal working conditions for the bearings, extended operating life, and exceptional stability for demanding applications and instruments such as scanning electron microscopes. It also features a compact rotor design that reduces power consumption and system footprint. Its unique bearing and dry lubricated suspension system is maintenance-free, eliminates oil and risk of contamination, and permits installation in multiple orientations.

"The new TwisTorr 304 FS is the smallest, most reliable, and energy-efficient high-vacuum pump available today," said Giampaolo Levi, vice president and general manager of Agilent's Vacuum Products Division; "[...] and we will continue our active collaboration with customers to identify their expanding needs and develop new advances in turbo pump design."

Related Links:
Agilent Technologies, Inc.
Agilent TwisTorr 304 FS


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.